Nebulous humors: Defining alloantibodies in the 21st century

Human Immunology

Volumn 70, Issue 8, 2009, Pages 623-626

  Warner, Paul ^a  

^a PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; FORECASTING; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSORBENT TECHNIQUES; ISOANTIBODIES; MICROSPHERES; ORGAN TRANSPLANTATION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; STATISTICS AS TOPIC; TISSUE AND ORGAN PROCUREMENT;

EID: 68049135735     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.04.015     Document Type: Article

References (10)

1. Kissmeyer-Nielsen F., Olsen S., Petersen V.P., and Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 2 (1966) 662-665
2. Patel R., and Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280 (1969) 735-739
3. Bray R.A., Nolen J.D., Larsen C., Pearson T., Newell K.A., Kokko K., et al. Transplanting the highly sensitized patient: The Emory algorithm. Am J Transplant 6 (2006) 2307-2315
4. Reinsmoen N.L., Lai C.H., Vo A., Cao K., Ong G., Naim M., et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 86 (2008) 820-825
5. Vaidya S. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Transplantation 85 (2008) 1046-1050
6. Bielmann D., Honger G., Lutz D., Mihatsch M.J., Steiger J., and Schaub S. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 7 (2007) 626-632
7. Gupta A., Iveson V., Varagunam M., Bodger S., Sinnott P., and Thuraisingham R.C. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?. Transplantation 85 (2008) 1200-1204
8. Gibney E.M., Cagle L.R., Freed B., Warnell S.E., Chan L., and Wiseman A.C. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 21 (2006) 2625-2629
9. van den Berg-Loonen E.M., Billen E.V., Voorter C.E., van Heurn C.W., Claas F.H., van Hooff J.P., et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 85 (2008) 1086-1090
10. Patel A.M., Pancoska C., Mulgaonkar S., and Weng F.L. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 7 (2007) 2371-2377